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Nonhomologous end joining (NHEJ) is central to the
repair of double-stranded DNA breaks throughout
the cell cycle and plays roles in the development
of the immune system. Although three-dimensional
structures of most components of NHEJ have
been defined, those of the catalytic region of DNA
ligase IV (LigIV), a specialized DNA ligase known
to work in NHEJ, and of Artemis have remained
unresolved. Here, we report the crystal structure
at 2.4 A˚ resolution of the catalytic region of LigIV
(residues 1–609) in complex with an Artemis
peptide. We describe interactions of the DNA-
binding domain of LigIV with the continuous epitope
of Artemis, which, together, form a three-helix
bundle. A kink in the first helix of LigIV introduced
by a conserved VPF motif gives rise to a hydro-
phobic pocket, which accommodates a conserved
tryptophan from Artemis. We provide structural
insights into features of LigIV among human DNA
ligases.
INTRODUCTION
DNA ligase IV (LigIV), one of three DNA ligases in higher eukary-
otes, plays a central role in the repair of DNA double-strand
breaks (DSBs) during nonhomologous end joining (NHEJ). In
human NHEJ, two DSB ends are brought into proximity by
DNA protein kinase (DNA-PK) comprising the Ku70/80 hetero-
dimer and DNA-PK catalytic subunit (DNA-PKcs) (Smith and
Jackson, 1999). The DNA ends are then processed by Artemis,
PNKP, polm, poll, TdT, and other proteins, and end joining is
achieved by the NHEJ ligase complex LigIV, XRCC4, and XLF-
Cernunnos (Lieber, 2010).
Artemis, a nuclease belonging to the metallo-b-lactamase
superfamily, is mutated in radiosensitive severe combined
immunodeficiency patients (Moshous et al., 2001). DNA-PKcs
recruits Artemis to the DNA ends through its C-terminal residues,
particularly L401 and R402 (Soubeyrand et al., 2006; Niewolik
et al., 2006). The complex is crucial for opening hairpin DNA in
V(D)J recombination (Ma et al., 2002). Artemis is activated by
the autophosphorylation of DNA-PKcs (Goodarzi et al., 2006).672 Structure 21, 672–679, April 2, 2013 ª2013 Elsevier Ltd All rightsIt has recently been found that Artemis (residues 485–495) also
interacts with LigIV (Malu et al., 2012).
Human DNA ligases have a conserved catalytic region
consisting of a DNA-binding domain (DBD), a nucleotidyltrans-
ferase domain (NTD), and an OB-fold domain (OBD)
(Tomkinson et al., 2006). Motifs I–VI in NTD and OBD are
conserved among DNA and RNA ligases and RNA-capping
enzymes (Shuman and Schwer, 1995). In addition, eukaryotic
DNA ligases have a further motif, Va, in OBD (Marchetti et al.,
2006). A covalent AMP-lysine intermediate is formed with the
catalytic lysine (K273) in motif I of LigIV (step 1) before the
AMP is transferred to the 50 phosphate of the DNA nick (step
2). The nick is then sealed by the formation of a phosphodiester
bond (step 3). DNA ligase is required for all steps (Shuman and
Lima, 2004).
LigIV has a tandem repeat of BRCT domains at the C terminus,
which interacts with XRCC4 (Critchlow et al., 1997). The interac-
tion stabilizes LigIV in vivo (Bryans et al., 1999) and stimulates the
activities of LigIV (Grawunder et al., 1997). The knockout of either
the Lig4 or Xrcc4 gene in mouse results in embryonic lethality
(Frank et al., 1998; Gao et al., 1998). Hypomorphic mutations
of LIG4 cause a rare disease known as LIG4 syndrome
(Chistiakov et al., 2009).
Although the crystal structures of the core NHEJ proteins
have been defined, the structure of the catalytic region of LigIV
has remained unsolved. Here, we report the crystal structure at
2.4 A˚ resolution of LigIV1–609 (residues 1–609) in complex with
Artemis485–495 (residues 485–495). The structure shows that
DNA ligases I and III share a similar fold but the catalytic
domain of LigIV carries unique inserts, which might be involved
in enzymatic activities of LigIV. We show that Artemis interacts
with the first two a helices of LigIV, forming a three-helix
bundle. A kink in the first helix of LigIV, introduced by
a conserved VPF motif, gives rise to a hydrophobic pocket,
which accommodates a conserved tryptophan (W489) from
Artemis.RESULTS AND DISCUSSION
Purification of LigIV
Possible C-terminal boundaries of the catalytic region of LigIV
were initially identified as residues 620, 647, and 653 from
a structure-based sequence alignment (Figure S1A available
online) and these were used to guide constructs for expression
of soluble protein in E. coli with glutathione S-transferase,
maltose-binding protein, and hexahistidine tags. However,reserved
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C Figure 1. Purification of LigIV Constructs
(A) Profile of the UV absorbance at 280 nm during
heparin affinity chromatography. The absorbance
during heparin is shown in blue. Arrows indicate
the ranges of fractions used for SDS-PAGE.
(B) SDS-PAGE gel of fractions eluted from
a heparin column. The molecular weight markers
are in column ‘‘M’’ and themolecular weights (kDa)
of the gel are shown on the left of the gel. Protein
bands are indicated on the right of the gel:
LigIV1–609 (residues 1–609 of LigIV), BRCT (residue
645–911 of LigIV) and XRCC4 (residue 1–213 of
XRCC4, all cysteines of which are mutated to
alanines).
(C) Profile of the UV absorbance at 280 nm during
size exclusion chromatography. The absorbance
during size-exclusion chromatography is shown
in red.
(D) SDS-PAGE gel of fractions eluted from a Su-
perdex 200 column. Themolecular weight markers
are identical to those shown in (B). Protein bands
are indicated on the right of the gel.
(E) SDS-PAGE gels of purified LigIV1–609. A total of
2 mg of both LigIV1–609 (left) and LigIV1–620 (right)
are shown with their molecular weights (kDa).
See also Figure S1.
Structure
Structure of Human DNA Ligase IV/Artemis Complexthis approach proved unsuccessful (data not shown), and
we explored an alternative experimental strategy. LigIV/
XRCC4DCTD;CtoA complex, in which the C-terminal region of
XRCC4 (residues 214–334) is omitted and all cysteines are
mutated to alanines (Ochi et al., 2012), was purified and di-
gested with four different proteases: trypsin, chymotrypsin,
papain, and subtilisin. We found that the catalytic region of
LigIV remained intact after being digested with subtilisin, but
less so with the other enzymes (Figure S1B), and was stable
and soluble after being purified from the digested complex
using heparin and gel filtration columns (Figures 1A–1D). Using
mass spectroscopic analysis of an SDS-PAGE gel of the cata-
lytic region of LigIV, the longest polypeptide observed
comprised residues 1–609 (data not shown). However, later
we found that constructs of LigIV comprising residues 1–609
(LigIV1–609) and residues 1–620 (LigIV1–620) were soluble in
E. coli cells when expressed with the N-terminal Sumo tag
(Figure 1E). Interestingly, the results of DNA ligation assays
suggest that the residues 610–620 are important for the enzy-
matic activity of LigIV (Figure S1C). A recent report also
suggests that the C-terminal helix of an archaeal DNA ligase
is important for its activity (Tanabe et al., 2012).
Structure of LigIV1–609/Artemis485–495 Complex
The crystallographic structure of Artemis485–495 in complex with
mercury-labeled LigIV1–609, in which nine mercury atoms are
coordinated by cysteines and methionines (Figure S2A), was
determined at 2.4 A˚ resolution (Table 1) using the multiwave-
length anomalous dispersion (MAD) method. The model of the
protein obtained from these mercury-labeled crystals was
refined against the X-ray data from the unlabeled protein crystals
at 2.55 A˚ resolution (see Table 1 for refinement statistics). We
also solved the structure of LigIV1–609 without Artemis485–495 atStructure 212.84 A˚ resolution. The structures proved to be very similar except
for the conformation of the loop between b11 and b12, which is
distorted by the binding of thiomersal in the mercury derivative
(data not shown).
The overall folds of the three catalytic domains are similar to
those of human DNA ligases I and III and archaeal DNA ligases
(Tomkinson et al., 2006) (Figures 2A and 2B). The first five resi-
dues, two loops (residues 58–59 and 115–123), and the last three
residues of LigIV1–609 are disordered in the crystals. Unique
structural features of LigIV1–609 are inserts between a5 and a6
of DBD (Insert1; residues 111–121), a15 and a16 of NTD (Ochi
et al., 2012), b12 and b13 of OBD (Insert2; residues 490–494)
and a different orientation of a5 of DBD (Figure 2C). In the crys-
tals, the structure of LigIV1–609 is captured in an open conforma-
tion and probably stabilized by burying a surface of area 1,104 A˚2
between OBD and NTD. This differs from other open conforma-
tions of archaeal DNA ligases available in the Protein Data Bank
(PDB) (Pascal et al., 2006; Petrova et al., 2012), the buried areas
of which are 337 and 80 A˚2, respectively. Given that the archaeal
structures have much smaller buried areas, they are likely to be
more flexible than human LigIV and the observed conformers
may be stabilized by crystallographic contacts.
In the derivative crystals of the LigIV1–609/Artemis485–495
complex, the poor density for adenosine is consistent with partial
adenylation as observed by DNA ligation assay (Figure S1C).
Although density for the aPO4 is evident, it is likely that AMP
has low occupancy (Figure S2B). In nonderivative crystals, the
electron density of adenosine is clearer in the catalytic pocket
of LigIV1–609 molecules (Figure S2C). In addition, extra density
near the adenosine is not explained by fitting AMP molecules,
indicating that ATP may bind to LigIV1–609 molecules that are
not adenylated. The density of b and g phosphates is absent in
the derivative crystals, probably because ATP diffuses from, 672–679, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 673
Table 1. Statistics of X-Ray Diffraction Data and Refinement Statistics of the Structures of LigIV1–609 and the LigIV1–609/Artemis485–495
Complex
Crystal LigIV1–609 without Artemis485–495
LigIV1–609 with Artemis485–495
Native
Thiomersal
Peak Inflection Remote
Beamline ESRF ID29 Diamond I04 Diamond I04 Diamond I04 Diamond I04
Wavelength (A˚) 0.9840 0.9795 1.0036 1.0093 0.9915
Resolution (A˚) 200-2.84 68.26-2.55 59.77-2.40 59.82-2.40 59.81-2.40
Space group P21 P22121 P22121 P22121 P22121
Cell (A˚)
a 68.29 68.26 68.57 68.63 68.60
b 104.36 105.48 105.14 105.21 105.16
c 120.04 121.08 121.98 122.04 122.14
b () 94.08 90 90 90 90
No. of unique reflections 39,757 27,784 34,874 34,931 34,946
Completeness (%) (highest shell) 99.4 (99.9) 96.0 (97.5) 99.3 (100) 99.3 (100) 99.3 (99.9)
Redundancy 3.4 2.8 3.5 3.5 3.5
Rmerge
a (%) 9.7 (56.8) 8.5 (56.2) 10.2 (52.8) 8.7 (53.6) 9.2 (54.8)
(highest shell)
I/s 10.1 (2.1) 8.8 (2.0) 8.1 (2.2) 8.5 (1.9) 8.5 (1.9)
(the highest shell)
Resolution (A˚) 47.84-2.84 59.48-2.55 59.84-2.40
Phasing method Molecular replacement Molecular replacement MAD
FOM N/A N/A 0.28
Overall score N/A N/A 48.25
Rcryst
b 19.35 (25.08) 18.00 (26.64) 17.63 (24.77)
(highest shell)
Rfree
c 24.55 (33.56) 23.36 (33.96) 22.53 (31.77)
(highest shell)
Rmsd
Bond (A˚) 0.009 0.008 0.008
Angle () 1.252 1.153 1.129
N/A, not applicable.
aRmerge = ShjIh  h I i j/ShIh, where Ih is the intensity of reflection h and h I i is the mean intensity of all symmetry-related reflections.
bRcryst = SjjFobsjjFcalcjj/SjFobsj, where Fobs and Fcalc are observed and calculated structure factor amplitudes.
cAs for Rcryst but using a random subset of the data (about 5%) excluded from the refinement.
Structure
Structure of Human DNA Ligase IV/Artemis Complexthe binding site while the crystals are soaking in thiomersal solu-
tion, as observed by others (Ha˚kansson et al., 1997; Pascal et al.,
2006).
Interaction between LigIV1–609 and Artemis485–495
Artemis485–495 interacts with a1 and a2 of LigIV to form a three-
helix bundle, burying 436 A˚2 of the surfaces of LigIV1–609 and
Artemis485–495 (Figure 2B). a1 has a kink produced by the proline
P15 (Figure 2D), which is conserved in higher eukaryotic organ-
isms (Figure S2E).W489 of Artemis (italic font for the residues of
Artemis), which is an important conserved (Figure S2D) residue
for LigIV interaction (Malu et al., 2012), makes a hydrogen
bond from its Nε to the side chain of D18 of LigIV. It also makes
van derWaals contacts with the conserved V14 in a hydrophobic
pocket of LigIV, the conformation of which is constrained by I145
in a7 of LigIV (Figure 2D). The interaction of the side chain of
W489 of Artemis in the hydrophobic pocket appears to be stabi-674 Structure 21, 672–679, April 2, 2013 ª2013 Elsevier Ltd All rightslized by further interactions of F492 of Artemis with F49 of LigIV
and F493 of Artemis with F42 of LigIV (Figure 2D), consistent with
the earlier report that W489, F492, and F493 mutations to
alanines disrupt the interaction between Artemis and LigIV
(Malu et al., 2012). Additionally, P487 is localized in a hydro-
phobic pocket formed by F49, A52, and L53 (Figure 2D). After
we submitted our manuscript, De Ioannes et al. reported the
structure of DBD of LigIV in complex with Artemis485–495 (De
Ioannes et al., 2012). Comparison of the two structures indicates
very similar interactions between LigIV and Artemis (the root-
mean-square deviation [rmsd] of Ca atoms of the structures is
0.975 A˚ calculated using LSQKAB in CCP4; Kabsch, 1976).
However, the rmsd of their and our structures without Artemis
is 6.88 A˚, which is mainly a consequence of a difference in the
conformations of a2 and the region after a10 (Figure S2F). How-
ever, the conformations of a2 with and without Artemis485–495
in our structures are very similar (Figure S2F). The differencereserved
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Figure 2. Structure of the LigIV1–609/Artemis485–495 Complex
(A) Schematic representation of the domains of LigIV. The same color scheme for the domains is used in all figures throughout this paper.
(B) Overall structure of LigIV1–609. Missing parts are represented by dotted lines.
(C) Unique inserts of LigIV1–609 and comparisons with LigI and LigIII. Top: an insert in OBD (blue) is shown. LigI and LigIII are shown in gold and cyan, respectively.
Bottom: the difference in orientation of the a5 is shown. The loop between a5 and a6, shown as a pink dotted line, is disordered in the crystal structure of LigIV1–609.
(D) Stereo image of LigIV1–609 with the Artemis485–495. The first 53 residues of LigIV1–609 (pink) are shownwith Artemis485–495 (cyan). A disordered loop between a2
and a3 is represented by a gray dotted line. A hydrogen bond between D18 andW489 is shown by a black dotted line. Residues of LigIV1–609 are labeled in regular
characters, whereas those of Artemis485–495 are in italic.
(E) Conserved interaction motif VP(F/Y) in LigIV1–609 and LigI. The color scheme of LigIV1–609/Artemis485–495 is the same as in (D). LigI is shown in gold. Residues
with ‘‘(I)’’ are from LigI.
See also Figure S2.
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Figure 3. Structural Models of Closed and
DNA-Bound Conformations of LigIV1–609
(A) Model of the closed conformation of LigIV1–609.
Insert1 (residues 111–121) and Insert2 (residues
490–494) are circled with black dotted lines.
(B) Ten RapperTK models of Insert1. The modeled
loop that has the least contact with OBD (surface
presentation) is shown in cartoon representation;
the others are displayed in ribbon representation.
(C) Ten RapperTK models of Insert2. The modeled
loop that has the least contact with DBD (surface
presentation) is shown in cartoon representation;
others are displayed in ribbon representations.
(D) Model of the DNA-bound conformation of
LigIV1–609. DNA is from the structure of human
LigIII (PDB code 3L2P).
(E) DNA-bound model of LigIV1–609 (blue) compared
with the structures of LigI (gold) and LigIII (cyan).
Residues shown are key residues interacting with
the base sugar of the 30 end of the DNA nick.
Structure
Structure of Human DNA Ligase IV/Artemis Complexbetween the two studies is probably due to the presence in our
structure of NTD, which stabilizes the conformation of the region
after a10 via contacts with a11, the following loop and that
connecting a12 and NTD. a2 interacts with this region and its
conformation is likely affected by it.
There are about 100 residues between the DNA-PKcs and Li-
gIV binding regions of Artemis, so both LigIV and DNA-PKcsmay
bind Artemis simultaneously. Interestingly, the polypeptide
sequence of the DNA-PKcs-interaction region of Artemis is not
as well conserved over evolutionary time as that of the LigIV-
interaction region (Figure S2D). This indicates that LigIV probably
does recruit Artemis without DNA-PKcs in some organisms
during DNA repair. The interaction would increase the local
concentration of the interaction partners and allow repair of
DSBs to occur more rapidly and efficiently.
Intriguingly, a similar interaction between LigIV and Artemis
can be found within LigI, where residues Y273(I) to G284(I)
[‘‘(I)’’ for the residues of LigI] occupy similar positions to residues676 Structure 21, 672–679, April 2, 2013 ª2013 Elsevier Ltd All rights reservedof the Artemis peptide (Pascal et al., 2004).
a1 of LigI also has a kink introduced by the
presence of a proline [P288(I)]. Further-
more V287 has van der Waals contacts
with W281(I) (Figure 2E) that are similar to
those mediating the interaction between
LigIV and Artemis. The conserved VP(F/Y)
is thus a tryptophan interaction motif in
LigI and LigIV.
Insights into Adenylation and DNA
Ligation
OBD undergoes a large conformational
change so that motif VI in OBD can be
proximal to the catalytic pocket and is
able to adenylate the catalytic lysine in
DNA ligases (Pascal et al., 2004). In order
to obtain insights into the mechanism of Li-
gIV, the closed conformation of LigIV was
modeled by superimposing each domainonto the structure of P. furiosus DNA ligase (Nishida et al.,
2006). In the initial model, Insert1 between a5 and a6 of DBD
clashed with OBD (Figure 3A). Also, the insert between b12
and b13 (Insert2) clashed with a10 and a11 of DBD (Figure 3A).
In order to investigate conformations that the loops might take
in the closed conformation, ten ab initio models of Insert1 and
Insert2 were built using RapperTK (Gore et al., 2007). This
demonstrated that Insert1 can take various conformations but
they must be oriented away from the catalytic pocket in order
to avoid contacts with OBD (Figure 3B). In a similar way, Insert2
must be positioned away from the catalytic pocket (Figure 3C).
These results indicate that very few conformations of Insert1
and Insert2 are compatible with the closed conformation and
that it may be more difficult to achieve in LigIV.
A model of the LigIV1–609/DNA complex was also built from
the structures of LigI and LigIII (Pascal et al., 2004; Cotner-
Gohara et al., 2010) (Figure 3D). Although key catalytic residues
involved in ligation are conserved among human DNA ligases
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Figure 4. LIG4 Syndrome Mutations in the
Structure of LigIV1–609
(A) Map of residues related to LIG4 syndrome.
Residues, mutations of which cause LIG4 syn-
drome, are shown in a stick representation and
magenta. The residues after R580 and R588 are
colored in yellow and orange.
(B) Mutation T9I. I9 (gray) is superimposed onto T9
(magenta). S12 and Q146 are residues having
hydrogen bonds with T9. The Artemis peptide is
shown in a cartoon representation.
(C) Mutation M249V. V249 (gray) is superimposed
onto M249 (magenta).
(D) Mutation G469E. E469 (gray) is superimposed
on G469.
Structure
Structure of Human DNA Ligase IV/Artemis Complex(Pascal et al., 2004; Cotner-Gohara et al., 2010), LigIV does
not have the phenylalanine that exhibits p stacking with the
ribose of the 30 side of the DNA nick (Figure 3E). Instead, LigIV
has K345, a residue that is conserved from human to fly
(Figure S2E). Therefore, K345 allows more flexibility in the
30-end detection. Another unique feature of the DNA-bound
model of LigIV is that Insert1 is located close to DNA, suggesting
that it may be involved in DNA binding. These unique features
might assist LigIV ligate atypical substrates (e.g., a DNA nick
with a gap, mismatched DNA, and poly-T ssDNA) (Gu et al.,
2007a, 2007b).
LIG4 Syndrome Mutations
We have previously shown that LIG4 syndrome mutations
R278H, Q280R, H282L, and Y288C have structurally important
consequences (Ochi et al., 2012). The complete model of NTD
in this study is consistent with this conclusion. Because residues
1–5 are disordered in the crystals, the structure provided no
insights into how A3V is related to LIG4 syndrome. However,
the structure of LigIV1–609 defines the locations of T9, M249,
and G469, the heterozygous mutations of which cause LIG4
syndrome (O’Driscoll et al., 2001; Toita et al., 2007) (Figure 4A).Structure 21, 672–679, April 2, 2013Potential effects of the mutations were
assessed using Modeler to build struc-
tures of the mutants (Sali and Blundell,
1993). T9 makes polar contacts with
S12 and Q146 (Figure 4B). The loss of
the interactions in the T9I mutation may
increase the flexibility of the residues
preceding I9. M249 stabilizes the confor-
mation of W447, which is a part of the
catalytic pocket and interacts with K432,
restraining its position (Figure 4C). K432,
a residue in motif IV, directly interacts
with the N1 atom of the adenine (Shuman,
2009). Therefore, the M249V mutation
most likely leads to instability of the
catalytic pocket due to the increased
flexibility of K432 and W447. Because
G469 is buried between tryptophan
side chains, the G469E mutation leads
to stereochemical clashes (Figure 4D)
and likely gives rise to conformationalchanges in the structure of OBD, which may affect adenylation
and ligation of LigIV.
EXPERIMENTAL PROCEDURES
Constructs and Protein Purification
The DNA sequences encoding human LigIV1–609 and LigIV1–620 were amplified
from the coexpression vector of LigIV/XRCC4DCTD;CtoA (Ochi et al., 2012) and
cloned between KpnI and HindIII sites of the pOPINS vector (a generous gift
from Dr. Ravi Nookala and Angela Pacitto), which has an N-terminal hexahis-
tidine followed by a Sumo tag. The purification of the proteins was performed
using nickel affinity, heparin, hydrophobic interaction, and size exclusion
columns. See Supplemental Experimental Procedures for further details
and for purification of LigIV1–609 after proteolysis of LigIV/XRCC4DCTD;CtoA.
Artemis485–495 was synthesized by Mr. Mike Waldon at the PNAC facility,
Department of Biochemistry, University of Cambridge. The construct and
purification of the LigIV/XRCC4 complex was described elsewhere (Ochi
et al., 2012).
Crystallization and Structural Determination
LigIV1–609 with and without Artemis485–495 was crystallized using vapor diffu-
sion method in 100 mM MES (pH 5.6–5.7), 2.0 M (NH4)2SO4, 10 mM YCl3.
Crystals appeared in 1 day and reached maximum size in 3 days. For the
native data, the crystals were transferred to a cryosolution (27% [v/v] glycerol,
73% [v/v] reservoir) before being frozen in liquid nitrogen. For theMADdata, theª2013 Elsevier Ltd All rights reserved 677
Structure
Structure of Human DNA Ligase IV/Artemis Complexcrystals were soaked in 1 mM thiomersal for 120 min and then back soaked in
the crystallization solution for 150min. The derivative crystals were then frozen
in liquid nitrogen after being protected with the cryo solution. See Supple-
mental Experimental Procedures for more details regarding crystallization.
X-ray data sets of the LigIV1–609/Artemis485–495 complex and LigIV1–609 were
collected at Diamond (Oxford, UK) synchrotron radiation source and European
Synchrotron Radiation Facility (Grenoble, France), respectively. The data of the
complex were processed using iMOSFLM (Battye et al., 2011) and then scaled
using Pointless and Scala (Evans, 2006) or Aimless (Evans, 2011). The data of
LigIV1–609 were processed and scaled using XDS (Kabsch, 2010). The phenix.
autosol module of PHENIX suite (Adams et al., 2010) was used to calculate
experimental phases from the thiomersal data using MAD methods. The initial
model was built using the phenix.autobuilt module, which created 80% of the
polypeptide chains. The model was manually modified using Coot (Emsley
et al., 2010) and refined using the phenix.refine module. These steps were
repeated several times. The refined-protein model determined by MAD with
the thiomersal data was used as the probe for molecular replacement with
thewild-typeandLigIV1–609withoutArtemis485–495datausing thephenix.phaser
module and refined as described above for the thiomersal data. The figures
illustrating structures were created using PyMOL (PyMOL Molecular Graphics
System version 1.2r1, Schro¨dinger). Buried surface areas were calculated
using protein interfaces, surfaces, and assemblies service (PISA) at European
Bioinformatics Institute (http://www.ebi.ac.uk/pdbe/prot_int/pistart.html).
Modeling
Models of Insert1 and Insert2 were built using RapperTK (Gore et al., 2007).
The structure of LigIV1–609 was used as the input and then ten loops for each
insert were generated without using the restraint of electron density. Modeler
(Sali and Blundell, 1993) was used to create a model of the protein with the
mutations causing LIG4 syndrome. The best model was that with the lowest
object function selected from 30 generated models.
DNA Ligation Assays
See Supplemental Experimental Procedures for details regarding the DNA
ligation assays.
ACCESSION NUMBERS
The coordinates and structure factors of the LigIV1–609/Artemis485–495 complex
and LigIV1–609 have been deposited in the PDB with the accession numbers
3W1B, 3W1G, and 3W5O, respectively.
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mental Procedures and can be found with this article online at http://dx.doi.
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